Elena Castro is a medical oncologist and group leader at Hospital Universitario 12 de Octubre, in Madrid.
Dr Castro received her medical degree and PhD from the University of Salamanca. After training in medical oncology, she completed a fellowship in cancer genetics and prostate cancer at the Institute of Cancer Research and The Royal Marsden Hospital, (London). In 2013, she returned to Spain and joined the Prostate Cancer Clinical Research Unit at the Spanish National Cancer Research Center (CNIO).
Dr Castro is a translational researcher whose interest range from preclinical studies to clinical trials. Her work has focused on the clinical implications of germline and genomic variants in prostate cancer. She has also been involved in numerous clinical trials investigating new treatment strategies for patients with prostate cancer.
Over her career, Dr Castro has received several grants and awards to support her research. She has authored numerous manuscripts, including several important papers on prostate cancer. Dr Castro is actively in involved in ESMO and EAU.
